Aberdeen Asset Management’s Celgene Corp CELG Stock Holding History

Aberdeen Asset Management’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$20M	Sell	154,040 -1,656	-1%	-$203K	0.07%	253
2017 Q1	$19.4M	Sell	155,696 -15,923	-9%	-$1.91M	0.07%	239
2016 Q4	$19.9M	Sell	171,619 -10,168	-6%	-$1.13M	0.08%	224
2016 Q3	$19M	Sell	181,787 -76,133	-30%	-$8.24M	0.07%	237
2016 Q2	$25.4M	Sell	257,920 -52,685	-17%	-$5.45M	0.09%	170
2016 Q1	$31.1M	Sell	310,605 -23,804	-7%	-$2.45M	0.11%	122
2015 Q4	$39.2M	Buy	334,409 +25,920	+8%	+$3M	0.13%	101
2015 Q3	$33.4M	Sell	308,489 -8,048	-3%	-$999K	0.11%	108
2015 Q2	$36.6M	Sell	316,537 -8,412	-3%	-$962K	0.11%	109
2015 Q1	$37.5M	Sell	324,949 -26,640	-8%	-$3.18M	0.1%	111
2014 Q4	$39.3M	Sell	351,589 -82,520	-19%	-$8.7M	0.1%	115
2014 Q3	$41.1M	Sell	434,109 -75,173	-15%	-$6.78M	0.09%	134
2014 Q2	$43.7M	Buy	509,282 +423,044	+491%	+$32.2M	0.09%	136
2014 Q1	$6.02M	Sell	86,238 -400	-0.5%	-$31.7K	0.02%	168
2013 Q4	$7.26M	Hold	86,638	–	–	0.02%	148
2013 Q3	$6.67M	Sell	86,638 -8,820	-9%	-$618K	0.02%	148
2013 Q2	$5.58M	Buy	+95,458	New	+$5.74M	0.02%	160

Other funds holding CELG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Aberdeen Asset Management's CELG Position: Q2 2017 in Review

Aberdeen Asset Management reduced its Celgene Corp (CELG) stake by 1.1% in Q2 2017, selling an estimated $203K and leaving 154,040 shares worth $20M. The position accounts for 0.07% of the portfolio, ranked #253.

Aberdeen Asset Management first reported a position in CELG in Q2 2013 and has held it in 17 quarters since. The position peaked at $43.7M in Q2 2014. 1,428 funds tracked by Wall St. Rank hold CELG as of Q2 2017.

Aberdeen Asset Management held 154,040 shares of Celgene Corp worth $20M as of Q2 2017.
Aberdeen Asset Management sold 1,656 Celgene Corp shares in Q2 2017, an estimated $203K.
Celgene Corp made up 0.07% of Aberdeen Asset Management's portfolio in Q2 2017, its #253 holding.
Aberdeen Asset Management first reported a position in Celgene Corp in Q2 2013 and has held it in 17 quarters since.
Aberdeen Asset Management's Celgene Corp position peaked at $43.7M in Q2 2014.
1,428 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2017.

Based on Aberdeen Asset Management's 13F filing for Q2 2017, filed 10 Aug 2017.